Innovative Surgical Platform Emulates Multi-Port Laparoscopy

The controls of each instrument are used separately outside of the body so as to closely mimic traditional laparoscopic equipment; surgeons actually feel as if they are manipulating two different tools, each within their own trocar.

Since the FMX314 is compatible with a standard laparoscopic trocar, it enables surgeons to perform procedural steps ergonomically, with fewer port-site complications, less post-operative pain, faster recovery, and improved cosmesis. Additional benefits include lower usage of analgesics and fewer readmissions for hernias and incision-site infections. The FMX314 surgical system is a product of Fortimedix Surgical (Nuth, The Netherlands), and has been approved by the U.S. Food and Drug Administration (FDA).

“Closely mimicking conventional, multi-port laparoscopy makes FMX314 easy to use and enables surgeons to perform procedural steps ergonomically, allowing for a comfortable and secure single-port approach,” said Marc van de Graaf, VP of global business development for Fortimedix Surgical. “With its unique sizing and ease-of-use, we believe FMX314 will deliver on the promise of single-port surgery, elevating the standard of care in laparoscopy.”

Single-incision laparoscopic surgery (SILS) is used to perform many types of surgery, including adjustable gastric banding, appendectomy, cholecystectomy, hernia repair, hysterectomy, and others. When compared with traditional multi-port laparoscopic techniques, benefits include less postoperative pain, less blood loss, faster recovery time, and better cosmetic results. Despite the potential advantages, there may also be complications, including significant postoperative pain, injury to organs, bleeding, infection, incisional hernia, intestinal adhesions, and scarring.

Related Links:
Fortimedix Surgical